Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoreactive somatomedin A in human serum.

K Hall, J Brandt, G Enberg

    The Journal of Clinical Endocrinology and Metabolism
    |February 1, 1979
    PubMed
    Summary

    A novel radioimmunoassay (RIA) accurately measures somatomedin A (SM-A) in serum. This assay differentiates SM-A levels in acromegaly, GH deficiency, and healthy individuals, revealing differences in carrier protein binding.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thyroxin displacement from single and combined thyroid hormone binding proteins by various test substances.

    Archives of toxicology·2026
    Same author

    The association of low-level air pollution with birth weight in a register-based study: potential effects below WHO AQ guidelines.

    BMC pregnancy and childbirth·2025
    Same author

    Cardiometabolic Health Effects of Air Pollution, Noise, Green Space, and Socioeconomic Status: The HERMES Study.

    Research report (Health Effects Institute)·2025
    Same author

    Birth Cohort Studies of Long-Term Exposure to Ambient Air Pollution in Early Life and Development of Asthma in Children and Adolescents from Denmark.

    Research report (Health Effects Institute)·2024
    Same author

    Long-Term Exposure to AIR Pollution and COVID-19 Mortality and Morbidity in DENmark: Who Is Most Susceptible? (AIRCODEN).

    Research report (Health Effects Institute)·2024
    Same author

    Patient-reported outcomes (PROs) as a routine measure for cancer inpatients: the final missing piece of the puzzle?

    Annals of oncology : official journal of the European Society for Medical Oncology·2018

    Area of Science:

    • Endocrinology
    • Biochemistry
    • Immunology

    Background:

    • Somatomedin A (SM-A) plays a crucial role in growth and metabolism.
    • Accurate measurement of SM-A is essential for diagnosing endocrine disorders like acromegaly and growth hormone (GH) deficiency.

    Purpose of the Study:

    • To develop and validate a radioimmunoassay (RIA) for quantifying somatomedin A (SM-A) in human serum.
    • To compare SM-A levels in patients with acromegaly, GH deficiency, and healthy controls using the developed RIA.

    Main Methods:

    • Development of a Sepharose-bound antibody-based radioimmunoassay (RIA) for SM-A.
    • Measurement of SM-A, insulin-like growth factors 1 and 2, and somatomedin C in serum samples.
    • Correlation analysis with radioreceptor assay (RRA) and gel chromatography for characterization.

    Main Results:

    • The RIA demonstrated high correlation (r=0.93) with RRA for SM-A.
    • Mean serum SM-A levels differed significantly across patient groups: acromegaly (8.7 U/ml), GH deficiency (0.24 U/ml), and healthy subjects (1.15 U/ml).
    • Acromegalic serum showed SM-A bound to a carrier protein, absent in GH-deficient serum; 90% of SM-A was low molecular weight after pH treatment.

    Conclusions:

    • The developed RIA provides a reliable method for SM-A determination in clinical serum samples.
    • RIA reveals distinct SM-A profiles and carrier protein interactions in acromegaly versus GH deficiency.
    • Further characterization of SM-A and its binding proteins can aid in understanding growth-related endocrine disorders.

    Related Experiment Videos